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Abstract
Background: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency is a rare inborn error of
metabolism characterized by recurrent metabolic crises caused by fasting, intercurrent illness and excessive physical
exercise. Non ketotic hypoglycemia is normally the cause of primary symptoms but without an immediate
treatment the illness can evolve into a worsening metabolic state resembling the Reye’s syndrome that may cause
the patient’s death. We report a case with some clinical and therapeutic features not previously described.
Case presentation: Patient with HMG-CoA lyase deficiency whom after diagnosis at 2 years of age was re-
admitted 12 years later, after severe metabolic decompensation following consumption of alcohol. Despite a quick
correction of hypoglycemia, within the following few hours, the patient fell into a coma. Suspecting intracranial
hypertension (ICH), the patient required mechanical ventilation. Although liver cytolysis was minimal,
hyperamoniemia reached 1394 μmol/L, returning to normal, a few hours after administering sodium phenylacetate
and sodium benzoate, whose use has not been reported in these patients. Brain edema was evidenced in the
computed tomography and by the magnetic resonance imaging that determined that the edema was cytotoxic, as
quantified with the restriction of diffusion in the apparent diffusion coefficient map. During the recovery of the ICH,
we belatedly, detected vasospasm moderate-severe that was treated with nimodipine. Currently, the patient
maintains clinical normality.
Conclusions: The alcohol consumption must be avoided in patients with HMG-CoA lyase deficiency. In our patient
hyperamoniemia was effectively treated with sodium phenylacetate and sodium benzoate. Magnetic resonance
imaging showed and quantified the cytotoxic brain edema. Belatedly, a cerebral vasospasm was an additional
mechanism of cerebral injury. None of these observations has been previously reported.
Keywords: HMG-CoA lyase deficiency, Reye-like syndrome, Alcohol consumption, Hyperamoniemia, Sodium
phenylacetate and sodium benzoate, Cytotoxic brain edema, Cerebral vasospasm
Background
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
lyase deficiency is a recessive autosomal hereditary
disease described for the first time by Faull et al. [1].
This mitochondrial enzyme catalyzes the cleavage of
HMG-CoA to form acetyl-CoA and acetoacetate, which
is the common final step of ketogenesis and leucine
degradation [2]. The illness is characterized by recurrent
metabolic crises which generally start in the early
neonatal period (30%) or in the first year of life (60%)
[3]. These crises are caused by fasting, intercurrent
illness and excessive physical exercise [2].
The non ketotic hypoglycemia is normally the cause of
primary symtoms. But the illness can evolve into a
worsening metabolic state resembling the Reye’s
syndrome [3]. Such crises can cause death in 20% of
cases and serious long term health predicaments such as
psychomotor retardation, epilepsy, hepatic steatosis,
pancreatitis or dilated cardiomyopathy [2].
Patients with HMG-CoA lyase deficiency show a
diagnostic urinary organic acids pattern [1, 4]. Confirm-
ation diagnosis requires determining the enzyme activity
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or a genetic study. The altered gene is the HMGCL,
located on chromosome 1p36.1 and 48 mutations have
been identified [5, 6]. The most common in Mediterranean
countries and the second most common in the world is the
E37X [7, 8].
We report a new case of HMG-CoA lyase deficiency
whom after the diagnosis at 2 years of age was once
again re-admitted 12 years later, after severe metabolic
decompensation following consumption of alcohol.
Case presentation
Following 12 h of food rejection and vomiting, due to a
cold, our 2 years old Spanish child was admitted into the
Pediatric Intensive Care Unit (PICU) with clinical symp-
toms of hypoactivity, hypotonia, vomiting and transient
loss of consciousness. The patient had no previous
illness of interest. The patient’s parents were Moroccan,
consanguineous and without any illness of note.
Patient examination on admission showed a Glasgow
Coma Scale (GCS) of 13–14, tiredness, hypotonia and mild
hepatomegaly. Vital signs were all normal. Blood analysis
highlighted severe hypoglycemia (29 mg/dL) without keto-
sis, moderate metabolic acidosis and hyperlactatemia
(10.3 mmol/L). The ammonium level was slightly elevated
(86.7 μmol/L). Following the intravenous administration of
glucose there was an immediate and sustained stabilization
of blood glucose. The following 12 h also saw the
normalization of metabolic acidosis, hyperlactatemia and
consciousness. An electroencephalogram (EEG) showed no
significant pathological alterations and the magnetic re-
sonance imaging (MRI) indicated small hyperintensity in
FLAIR and T2 sequences in the frontal subcortical white
matter suggestive of demyelination areas. The metabolic
study showed increased urinary metabolites of leucine,
suspecting HMG-CoA lyase deficiency. The diagnostic
confirmation was done via a genetic study: the patient was
homozygous for the E37X mutation. The patient received
treatment with L-carnitine and outpatient control until
3 years of age when he cut short his attendance.
At 14 years of age, he returned to our Pediatric Emer-
gency Department due to a loss of consciousness follow-
ing vomiting brought on by alcohol consumption a few
hours before (3 vodkas with coke). The family made no
reference to previous illnesses or admissions, excepting
some infant resolved episodes of hypoglycemia. On
examination the patient was unconscious, with ocular
revulsion, generalized tremors and hypertonia, suggest-
ive of generalized tonic seizure. All other vital signs
were as normal. A blood analysis highlighted severe
hypoglycemia (8 mg/dL) without ketosis, metabolic
acidosis (pH 7.28, pC02 32.4 mmHg, HC03
− 14.9 mEq/L,
base excess −10.4 mEq/L) and hyperlactatemia (5.6 mmol/
L). The biochemical blood evolution is shown in Table 1.
A quick correction of hypoglycemia was performed with
intravenous administration of glucose, which led to an
initial recovery of the patient’s awareness (GCS 13–14).
Despite maintaining normal glucose levels, the follow-
ing 4 h witnessed further neurological deterioration,
alternating between phases of agitation and progressive
lethargy. Suspecting intracranial hypertension (ICH), the
patient was admitted to the PICU. Treatment was initi-
ated with anti-edema measures (mannitol, furosemide
Table 1 Blood biochemistry evolution. N-Carbamil glutamate (100 mg/kg through nasogastric tube) was administered at 2 h after
PICU admission, and Sodium phenylacetate and sodium benzoate (Ammonul® 55 mL/m2) was administered after 8 h. A rapid
increase in hyperammonemia may be observed, peaking at 7 h after admission to the PICU and a subsequent rapid decline to
normalization between 14 and 19 h. The liver and Kidney function improved from 24 h of hospital admission. AST, aspartate
aminotransferase; ALT, alanine aminotransferase; PT, Prothrombin Time; QI, Quick index; APTT (sec) activated partial thromboplastin time;
CK, creatine phosphokinase; CRP, C-reactive protein
PICU Admission 6 h 7 h 11 h 14 h 19 h
Ammonium (μmol/L) 669 1075 1394 522 70,6 24,4
Hospital Admission 12 h 24 h 48 h 72 h 5° day
Urea (mg/dL) 39 48 102 69 53 35
Creatinine (mg/dL) 0.92 1.25 1.31 0.94 0.59 0.41
Uric acid (mg/dL) - - - 13.4 11.1 5.9
AST/ALT (U/L) 74/42 172/92 157/104 82/82 42/58 38/54
Total Bilirubin (mg/dL) 1.83 2.2 0.86 0.83 0.65 0.37
PT (sec) / QI (%) 19.8/51 25.8/35 26.7/32 16.3/65 11.1/100 -
APTT (sec) 30.2 31 37.5 37.3 30 -
Factor VII (%) - - 16.8 45.2 - -
D-dimer (ng/mL) - 161 - 410 457 -
CK (U/L) 285 - 718 257 132 -
CRP (mg/L) 2.4 2.4 2.2 65.7 121.4 16
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and postural treatment), and intravenous administration
of L-carnitine (100 mg/kg). After the first measurement
of ammonium, carglumic acid was administered through
a nasogastric tube. An urgent cranial computed tomog-
raphy (CT) scan was performed, which detected chronic
defects in white matter but without signs of cerebral
edema. In the 8 h after PICU admission there was a contin-
ued deterioration to GCS < 9. The patient required invasive
mechanical ventilation. In order to treat the hyperam-
monaemia sodium phenylacetate and sodium benzoate was
administered intravenously and although continuous veno-
venous haemodiafiltration was prepared, it was not used
due to a rapid decline in hyperammonaemia until complete
normalization within a few hours (Table 1).
Using bispectral index monitoring (BIS), electrical
brain activity registered values between 25–40. At 24 h
the EEG showed severe and generalised signs of
slowdown in cerebral bioelectrical activity, transcranial
Doppler (TCD) a diffuse slight-moderate increase of
the pulsatility index (1.1–1.3), compatible with mild
ICH, and CT scan showed a diffuse worsening in the
cortical-subcortical differentiation and a decreased
size of ventricles and subarachnoid space. All consist-
ent with cerebral edema.
At 48 h, the EEG detected a presence of slow waves
but with remarkable bioelectrical improvement, by
which sedation was withdrawn. The TCD showed an
increase in average speeds (180–190 cm/s) in all the
territories with predominance in the left hemisphere,
compatible with moderate-severe vasospasm. Thus treat-
ment was started with intravenous nimodipine. The
patient maintained BIS values <50 in the following 12 h,
later waking up and being subsequently extubated after
72 h of PICU admission (GCS 13–14). The subsequent
MRI showed hyperintensity white matter signals in
FLAIR and T2 sequences, in relation to base metabolic
leucoencephalopathy (Fig. 1a), but also indicated new
sources which in the diffusion-weighted imaging,
showed a reduced apparent diffusion coefficient (ADC)
indicative of cytotoxic edema (Fig. 2a).
On the 8th day neurological examination was normal
as that of EEG and TCD testing, withdrawing treatment
with nimodipine. Once again, when the patient was
discharged we recommended continued treatment with
L-carnitine. The MRI performed at 8 months indicated a
normalization of ADC, but with the presence of specific
areas with increased signal in T2 and FLAIR sequences
indicative of definitive residual injury in the periven-
tricular brain parenchyma as well as those areas of
previous demyelination (Figs. 1b and 2b). Currently, the
patient maintains clinical normality.
Discussion
In patients with HMG-CoA lyase deficiency the main
mechanism that produces fasting hypoglycemia is an
excess of glucose use by the peripheral tissues, since
these cannot have ketones nor free fatty acids for oxi-
dation, due to the shortfall of secondary carnitine.
This deficit is the result of the excess of acyl-CoA,
which after esterification to acyl-carnitine, is lost in
the urine [2, 4, 6]. For these reasons, these patients
should maintain dietary supplementation with L-carnitine
(75–100 mg/kg/day) [9]. Our patient did not follow this
recommendation at the age of 14, probably because the
patient remained asymptomatic for several years and the
family lost consciousness of the chronic nature of this
illness. It is possible that this deficit facilitates the
development of Reye’s syndrome, as has been described
Fig. 1 Axial section MRI T2-weighted sequences at 72 h. Image a indicates an increased intensity in white matter of diffuse bilateral distribution.
Image b taken after 8 months; indicates resolution of the previous diffuse affectation, however the appearance of specific areas with increased
signal in the periventricular brain parenchyma predominantly of the left side, indicative of definitive residual injury
Muñoz-Bonet et al. Italian Journal of Pediatrics  (2017) 43:12 Page 3 of 5
in other enzymatic defects of fatty acid oxidation. In
addition, in this episode the consumption of alcohol
could aggravate the metabolic crisis by blocking the
neoglucogenesis from pyruvate.
As mentioned, the illness may evolve to a Reye
syndrome and has been reported to cause severe cytoly-
sis. However, in our patient only a minimum elevation
of transaminases occurred. Therefore, the absence of
hepatic cytolysis does not preclude the existence of a
serious hepatic encephalopathy. For these reasons, the
blood levels of ammonium must be determined in any
decompensation. In our patient intravenous benzoate
and sodium phenyl acetate has been a very effective
treatment of hyperammonaemia. It has been suggested
that this treatment could be useful in these patients [10]
but has not been reported previously. The evolution of
Quick index and Factor VII suggest that the liver syn-
thesis function was also affected. The normal values of
D-dimer support this hypothesis. The minimal cytolysis
could also explain the rapid normalization of liver
function and the recovery of the patient with detox and
supportive treatment in PICU.
Characteristically, the neuroimaging studies carried out
on these patients show diffuse cerebral white matter hypo-
density on CT scan and hyperintensity on T2 weighted
MRI studies [3, 5]. However, there is less information on
the findings of the neuroimaging tests during an acute
episode. In the MRI, we detected that the cerebral edema
was of the cytotoxic type with the restriction of diffusion
in the ADC map. In it, the swelling cell produces a
decrease in the extracellular space and a decrease in the
molecular diffusion that is quantified and that in our
patient was diminished in the initial study, normalizing in
the test carried out 8 months later. This finding has not
been previously described.
Cerebral infarction in these patients has been related
with biochemical mechanism and not with loss of blood
supply [11]. However, in addition to the ICH, in our
patient the TCD performed at 48 h detected another
vascular mechanism of brain injury not previously
described. As such the vasospasm could have belatedly
aggravated cerebral ischemic damage after the improve-
ment of the ICH. Perhaps this mechanism could explain
the ischemic cerebral infarction with vascular distribu-
tion described by Huemer et al. that occurred 4 days
after metabolic decompensation [12]. Despite the appar-
ent full clinical recovery of our patient, it should be
noted that the MRI performed after 8 months detected
residual injuries in the periventricular area of cerebral
parenchyma of left dominance, where the vasoespasm
detected by TCD was greater. For this reasons we think
that TCD monitoring must be used in this patients.
It has been reported by several authors that with age
there is an increased tolerance to fasting [2, 10]. How-
ever, we want to point out that this genetic disease does
not heal. Thus, in our patient the most serious metabolic
crisis occurred 12 years after diagnosis, when the family
had already lost conscientious awareness of the disease.
For these reasons, the family must be made aware of the
chronic nature of the disease.
Conclusions
The alcohol consumption must be avoided in patients
with HMG-CoA lyase deficiency because it can precipi-
tate and exacerbate the Reye-like syndrome episodes.
The absence of hepatic cytolysis does not preclude the
existence of a serious hepatic encephalopathy. In our
patient hyperamoniemia was effectively treated with
sodium phenylacetate and sodium benzoate. In the
acute episode MRI showed and quantified the cytotoxic
brain edema. Belatedly, a cerebral vasospasm was an
additional mechanism of cerebral injury. Finally this
patients must avoid fasting and maintain L-carnitine
supplementation.
Fig. 2 Diffusion-Weighted Imaging in MRI, comparing the ADC map, at 72 h (Image a) and after 8 months (Image b). It may be observed that
the circular region of interest to determine the ADC value in both images: with values of: 0,4 × 10−3 mm2/s at 72 h (restricted diffusion), whilst
after eight months the value was 0.7 × 10−3 mm2/s (normal ADC map value)
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